MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    The cross-talk between microglia-derived exosomes and brain printing biometrics as a diagnostic approach for Parkinson’s disease prior to motor symptoms implications

    M. Anwar, M. Fathi (Cairo, Egypt)

    Objective: To highlight the efficiency of using microglia-derived exosomes (MDEs) in cross-talk with the BPB technique for the early diagnosis of Parkinson’s disease (PD) Background:…
  • 2022 International Congress

    Natural progression of patients with Parkinson disease on less pulsatile levodopa therapy

    M. Lin, R. Laureno, A. Lenka (Washington, USA)

    Objective: To evaluate the natural progression of Parkinson disease (PD) in patients on less pulsatile levodopa therapy (LPT). Background: Previously we have shown that patients…
  • 2022 International Congress

    Ping Pong as a sport-based intervention to increase physical activity in people with Parkinson’s Disease

    J. Domingos, J. Fernandes, J. Dean, C. Godinho (Monte de Caparica, Portugal)

    Objective: The aim of the study was to assess participant’s experiences, satisfaction, and safety of a sport-based intervention (Ping pong combined with PD-specific exercise). Background:…
  • 2022 International Congress

    Is left handedness associated with Parkinson’s disease? Evidence from the E3N cohort study and Mendelian randomization.

    G. Pesce, PE. Sugier, C. Domenighetti, F. Artaud, T. Truong, E. Flamand-Roze, M. Canonico, A. Elbaz (Villejuif, France)

    Objective: To investigate the association of hand preference with Parkinson’s disease (PD) (1) in a large prospective cohort study and (2) through a Mendelian randomization…
  • 2022 International Congress

    Cholinergic Nucleus 4 Degeneration and Cognitive Impairment in REM Sleep Behavior Disorder

    C. Tan, H. Nawaz, S. Lageman, B. Berman, N. Mukhopadhyay, M. Barrett (Richmond, USA)

    Objective: To determine if there is evidence of cholinergic basal forebrain degeneration, i.e., reduced cholinergic nucleus 4 (Ch4) volume on MRI, in patients with REM…
  • 2022 International Congress

    White Matter Perivascular Spaces in Parkinson’s Disease are Associated with Decreased Cognition, Interrupted Sleep, and Less Physical Activity

    E. Donahue, S. Venkadesh, R. Foreman, J. Duran, V. Bui, D. Wing, A. Petkus, I. Litvan, E. Bayram, D. Schiehser, J. Choupan, M. Jakowec, G. Petzinger (Los Angeles, USA)

    Objective: To determine the association of Perivascular Spaces (PVS) and non-motor features in Parkinson’s disease (PD). Background: PVS are the fluid-filled spaces surrounding blood vessels…
  • 2022 International Congress

    Pronunciation characteristics of patients with Parkinson’s disease based on sustained vowel speech

    Y. Wen, X. Zou (Chengdu, China)

    Objective: This study attempted to objectively analyze the acoustic characteristics of PD by using dynamic laryngoscope DIVAS2.5 acoustic analysis system and Praat acoustic software, and provide…
  • 2022 International Congress

    PLA2G6-related dystonia-parkinsonism in identical twins manifesting at an advanced age: a case report and review of the literature.

    D. Sugar, K. Kompoliti (Chicago, USA)

    Objective: To report a rare presentation of a rare disease and illustrate the range of phenotype seen in PLA2G6-associated dystonia-parkinsonism (PLADP). Background: PLA2G6 encodes a…
  • 2022 International Congress

    Sex differences in vascular risk factors for Parkinson’s disease

    K. Tsutsumi, E. Shah, A. Siddiqui, I. Attaripour (Orange, USA)

    Objective: Our aim is to illustrate the incidence of vascular risk factors (VRF) in a cohort of patients with confirmed Parkinson's disease (PD) and characterize…
  • 2022 International Congress

    Priorities of PD patients for treatment of cognitive-driven ADL impairment

    I. Liepelt-Scarfone, M. Bentele, S. Becker, C. Altmann, E. Schaeffer, K. Michaelis, S. Solbrig, K. Brockmann (Tübingen, Germany)

    Objective: To define cognitive-driven impairments in activities of daily living (ADL) with high priority for rehabilitation ranked by Parkinson’s disease (PD) patients. Background: Impairments in…
  • « Previous Page
  • 1
  • …
  • 207
  • 208
  • 209
  • 210
  • 211
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley